40th Anniversary of the Journal of Antimicrobial Chemotherapy

Celebrating the Journal of Antimicrobial Chemotherapy’s 40th Anniversary

We have compiled a timeline to commemorate the 40th anniversary of the Journal of Antimicrobial Chemotherapy (JAC). The timeline highlights key milestones and articles in JAC’s history, including top cited, top downloaded and articles with high Altmetric scores. All articles featured in the timeline will be freely accessible until the 31st December 2016. Scroll right to start exploring.

1971-01-01 00:00:00

British Society for Antimicrobial Chemotherapy forms

The British Society for Antimicrobial Chemotherapy (BSAC) is formed with the intention of coordinating research into many new antimicrobial agents. Alasdair M. Geddes, Chairman of the first Editorial Board, looks back on the early years of BSAC and JAC.

1975-01-01 00:00:00

J. D. Williams

J. D. Williams is JAC's first Editor-in-Chief.

1975-01-01 00:00:00

Journal of Antimicrobial Chemotherapy launches

The Journal of Antimicrobial Chemotherapy launches. The Journal sets out to cater to a broad church of disciplines involved in the development and use of antibiotics and related agents, attracting authors and readers from the BSAC and beyond. The Journal’s first editorial was written by the first Editor-in-Chief, J. D. Williams.

1981-01-01 00:00:00

Ian Phillips

Ian Phillips of St Thomas’ Hospital, London takes over as the Journal’s Editor-in-Chief and introduces a new section in the first issue of each volume of the Journal, providing detailed guidance to authors.

1981-01-01 00:00:00

Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes

Does administering antifungal drugs in conjunction with liposomes enhance therapeutic activity in rodents?

1986-01-01 00:00:00

David Speller

David Speller of the Bristol Royal Infirmary becomes JAC’s new Editor-in-Chief. He and his team “wish to increase the proportion of articles dealing with well-conducted clinical investigations, and to evoke a vigorous correspondence on antimicrobial matters”.

1991-01-01 00:00:00

Roger Finch

Roger Finch fulfils the role of JAC’s Editor-in-Chief.

1993-01-01 00:00:00

Resistance of yeasts to azole-derivative antifungals

“There are relatively few specific antifungal agents...for the treatment of systemic mycoses, yet the incidence of such infections, particularly of those caused by Candida species among immunocompromised patients, is generally considered to have become extremely high.”

1996-01-01 00:00:00

Martin Wood

Martin Wood becomes the new Editor-in-Chief of JAC.

1997-01-01 00:00:00

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility

JAC describes a clinical strain of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin (MIC 8 mg/L).

1997-01-01 00:00:00

Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin

Which agents are more active than ciprofloxacin against gram-positive cocci?

2001-01-01 00:00:00

David Reeves

JAC welcomes David Reeves as its new Editor-in-Chief.

2003-01-01 00:00:00

Linezolid resistance in clinical isolates of Staphylococcus aureus

Linezolid is the first oxazolidinone antibiotic to be licensed for treatment of Gram-positive infections.

2006-01-01 00:00:00

Biosurfactants: potential applications in medicine

Biosurfactants have great potential for use in the medical science arena waiting to be fully exploited.

2006-01-01 00:00:02

Alan Johnson

Alan Johnson takes over as JAC’s Editor-in-Chief.

2010-01-01 00:00:00

Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria

“There is an urgent need for research into the effectiveness of combinations of oral antibiotics in the treatment of complicated UTI in ambulatory care and the impact on the epidemiology of resistance.”

2010-01-01 00:00:00

Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs)

How can resistance to a STAT-C develop?

2011-01-01 00:00:00

Impact Factor reaches 5.068

The Journal’s Impact Factor exceeds 5 for the first time.

2011-01-01 00:00:00

Impact of antimicrobial stewardship in critical care: a systematic review

Is antimicrobial stewardship associated with improved antimicrobial utilization in the intensive care unit?

2011-01-01 00:00:00

Surviving the first hours in sepsis: getting the basics right

Explore challenges in sepsis care and opportunities for further improvements.

2014-01-01 00:00:00

Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09

Which antibiotics are most commonly prescribed during ambulatory visits in the US? Find out in a study of antibiotic prescribing for adults in ambulatory care in the USA, 2007–09.

2015-01-01 00:00:00

Peter Donnelly

“Antimicrobial stewardship, or rather the lack of it, is the most important challenge today.” JAC welcomes Peter Donnelly as its new Editor-in-Chief.

2015-01-01 00:00:00

Antimicrobial stewardship: the role of scientists?

Do scientists have a responsibility to monitor and reduce our use of antibiotics?

2015-01-01 00:00:00

Bactericidal effects of triclosan in soap both in vitro and in vivo

Is antibacterial soap more effective than plain soap when hand-washing?

2016-01-01 00:00:00

40th Anniversary

Celebrate JAC’s 40th year and learn about the history of the Journal in Peter Donnelly’s editorial: ‘Celebrating 40 years of the Journal’.

2016-01-01 00:00:00

Antimicrobial susceptibility testing breakpoints and methods from BSAC to EUCAST

The BSAC Standing Committee on Antimicrobial Susceptibility Testing is one of several European national breakpoint committees that agreed in 2002 to harmonize clinical MIC breakpoints.

40th Anniversary of the Journal of Antimicrobial Chemotherapy

Launch
Copy this timeline Login to copy this timeline 3d

Contact us

We'd love to hear from you. Please send questions or feedback to the below email addresses.

Before contacting us, you may wish to visit our FAQs page which has lots of useful info on Tiki-Toki.

We can be contacted by email at: hello@tiki-toki.com.

You can also follow us on twitter at twitter.com/tiki_toki.

If you are having any problems with Tiki-Toki, please contact us as at: help@tiki-toki.com

Close

Edit this timeline

Enter your name and the secret word given to you by the timeline's owner.

3-40 true Name must be at least three characters
3-40 true You need a secret word to edit this timeline

Checking details

Please check details and try again

Go
Close